A trial, decoded

Hákon Hákonarson and deCODE genetics CEO Kári Stefánsson used to consider each other friends. Hákonarson, the former vice president of business development at the Icelandic biopharmaceutical company, used to ride horses with Stefánsson and spend time with him outside of work. That all ended in May, 2006, when Hákonarson left deCODE to direct and help form the new Center for Applie

Written byJonathan Scheff
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Hákon Hákonarson and deCODE genetics CEO Kári Stefánsson used to consider each other friends. Hákonarson, the former vice president of business development at the Icelandic biopharmaceutical company, used to ride horses with Stefánsson and spend time with him outside of work. That all ended in May, 2006, when Hákonarson left deCODE to direct and help form the new Center for Applied Genomics at the Children's Hospital of Philadelphia (CHOP).

On August 4, deCODE sued Hákonarson and four other former deCODE employees who moved to CHOP, arguing that the new CHOP genomics center was a direct competitor of deCODE, and that Hákonarson had acted as a "double agent" for CHOP during his final months at deCODE, recruited other former deCODE employees to do the same, and destroyed evidence of their misdeeds.

The defendants denied all allegations: "The notion that there was any 'plot' is preposterous," according to their response. Stefánsson knew ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies